Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma
Authors:
- Donna E. HanselDHDonna E. Hansel
- Eric PlattEPEric Platt
- Mohammed OrloffMOMohammed Orloff
- Jyoti HarwalkerJHJyoti Harwalker
- Swathi SethuSSSwathi Sethu
- Jessica L. HicksJHJessica L. Hicks
- Angelo De MarzoAMAngelo De Marzo
- Roxanne E. SteinleRSRoxanne E. Steinle
- Eric D. HsiEHEric D. Hsi
- Dan TheodorescuDTDan Theodorescu
- Christina B. ChingCCChristina B. Ching
- Charis EngCECharis Eng
- 1 June 2010
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 176 (6) , 3062-3072
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mammalian target of rapamycin (mTOR) pathway signalling in lymphomasExpert Reviews in Molecular Medicine, 2008
- Bnip3 Mediates the Hypoxia-induced Inhibition on Mammalian Target of Rapamycin by Interacting with RhebJournal of Biological Chemistry, 2007
- Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathwayJournal of Cell Biology, 2007
- Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Chemotherapy for Bladder Cancer: Treatment Guidelines for Neoadjuvant Chemotherapy, Bladder Preservation, Adjuvant Chemotherapy, and Metastatic CancerUrology, 2007
- Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenograftsMolecular Cancer Therapeutics, 2006
- mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 2006
- Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapyOncology Reports, 2006
- Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin PathwayClinical Cancer Research, 2006
- The Akt-mTOR tango and its relevance to cancerCancer Cell, 2005